eFFECTOR Therapeutics, Inc.
(NASDAQ : EFTR)

( )
EFTR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Finance » Financial Conglomerates
symbolcompany%chnglast%shortavg$volume
CCitigroup, Inc. 1.00%64.751.0%$1656.70m
LCIDLucid Group, Inc. -5.78%33.410.0%$1363.07m
AXPAmerican Express Co. 1.27%175.311.8%$728.80m
DWACDigital World Acquisition Corp. 0.59%69.390.0%$551.04m
RIOTRiot Blockchain, Inc. -2.12%14.330.0%$152.15m
DOCNDigitalOcean Holdings, Inc. -0.89%50.980.0%$123.43m
EQHEquitable Holdings, Inc. 0.46%33.090.0%$92.07m
JXNJackson Financial, Inc. (Michigan) 1.91%39.060.0%$39.48m
CFVICF Acquisition Corp. VI -2.74%11.350.0%$37.40m
IONQIonQ, Inc. 3.35%10.790.0%$37.19m
GGPIGores Guggenheim, Inc. 1.43%10.660.0%$33.54m
EXPIeXp World Holdings, Inc. -3.10%24.110.0%$27.50m
PLPlanet Labs PBC 2.61%5.500.0%$25.90m
FBCFlagstar Bancorp, Inc. -1.84%46.521.4%$21.29m
IPOFSocial Capital Hedosophia Holdings Corp. VI 0.46%9.890.0%$20.54m

Company Profile

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in San Diego, CA.